Biomarin Pharmaceutical (BMRN) EBT Margin (2009 - 2026)
Biomarin Pharmaceutical's EBT Margin was 6.20% in Q2 2026, down 29.89 percentage points from 36.09% a year earlier and down 12.23 percentage points from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) EBT Margin (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Biomarin Pharmaceutical's EBT Margin was 4.38% through Jun 30, 2026, down 23.04 percentage points year-over-year; for FY2025, it came in at 14.98%, down 4.01 percentage points from FY2024.
- EBT Margin shows a five-year change of +17.61 percentage points (FY2020 to FY2025).
- In earlier years, EBT Margin was 18.98% in FY2024 (+11.19 pp), 7.79% in FY2023 (+0.66 pp), 7.14% in FY2022 (+11.22 pp) and -4.08% in FY2021 (-1.45 pp).
- Quarterly EBT Margin has moved between -14.80% (Q4 2021) and 36.09% (Q2 2025) over five years.
- Compared with a year earlier, EBT Margin has declined for four straight quarters, with an average year-over-year change of -3.36 percentage points over the last eight quarters.
- The best year-over-year quarter for EBT Margin over five years was Q1 2022 (a gain of 21.06 percentage points); the worst was Q2 2026 (a drop of 29.89 percentage points).
- Per Business Quant data, BMRN's EBT Margin in the three quarters before Q2 2026 was 18.43% (Q1 2026), -3.10% (Q4 2025) and -3.39% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 41.75% |
| 10 | Biomarin Pharmaceutical | 11.51 Bn | 5.37 Bn | 786.91 Mn | 6.20% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.20% |
| Mar 31, 2026 | 18.43% |
| Dec 31, 2025 | -3.10% |
| Sep 30, 2025 | -3.39% |
| Jun 30, 2025 | 36.09% |
| Mar 31, 2025 | 31.95% |
| Dec 31, 2024 | 22.70% |
| Sep 30, 2024 | 18.03% |
| Jun 30, 2024 | 18.56% |
| Mar 31, 2024 | 16.27% |
| Dec 31, 2023 | 2.99% |
| Sep 30, 2023 | 7.17% |
| Jun 30, 2023 | 11.90% |
| Mar 31, 2023 | 9.52% |
| Dec 31, 2022 | -3.27% |
| Sep 30, 2022 | -0.38% |
| Jun 30, 2022 | 6.53% |
| Mar 31, 2022 | 25.84% |
| Dec 31, 2021 | -14.80% |
| Sep 30, 2021 | -11.29% |
API Access
Biomarin Pharmaceutical EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();